ZA922899B - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
ZA922899B
ZA922899B ZA922899A ZA922899A ZA922899B ZA 922899 B ZA922899 B ZA 922899B ZA 922899 A ZA922899 A ZA 922899A ZA 922899 A ZA922899 A ZA 922899A ZA 922899 B ZA922899 B ZA 922899B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical compositions
calcium deficiency
deficiency diseases
treating calcium
provides
Prior art date
Application number
ZA922899A
Other languages
English (en)
Inventor
Tudor Arvinte
Amelia Cudd
Judith Phillips
Original Assignee
Ciba Geigy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy filed Critical Ciba Geigy
Publication of ZA922899B publication Critical patent/ZA922899B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA922899A 1991-04-23 1992-04-22 Pharmaceutical compositions ZA922899B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919108634A GB9108634D0 (en) 1991-04-23 1991-04-23 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ZA922899B true ZA922899B (en) 1993-10-22

Family

ID=10693744

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA922899A ZA922899B (en) 1991-04-23 1992-04-22 Pharmaceutical compositions

Country Status (19)

Country Link
US (1) US5593962A (es)
EP (1) EP0510913B1 (es)
JP (1) JP3532580B2 (es)
KR (1) KR100245534B1 (es)
AT (1) ATE194775T1 (es)
AU (1) AU653395B2 (es)
CA (1) CA2066532C (es)
CY (1) CY2246B1 (es)
DE (1) DE69231263T2 (es)
DK (1) DK0510913T3 (es)
ES (1) ES2150418T3 (es)
GB (1) GB9108634D0 (es)
GR (1) GR3034414T3 (es)
IE (1) IE921278A1 (es)
IL (1) IL101622A (es)
MX (1) MX9201825A (es)
NZ (1) NZ242440A (es)
PT (1) PT510913E (es)
ZA (1) ZA922899B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5595760A (en) * 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
WO2000054797A2 (en) * 1999-03-17 2000-09-21 Novartis Ag Pharmaceutical compositions comprising tgf-beta
WO2001056594A1 (en) 2000-02-04 2001-08-09 Unigene Laboratories, Inc. Nasal calcitonin formulations
CA2507524C (en) 2002-09-27 2012-12-11 Zentaris Gmbh Administration form for pharmaceutically active peptides with sustained release and method for the production thereof
GB0422644D0 (en) * 2004-10-12 2004-11-10 Novartis Ag Organic compounds
GB0511269D0 (en) 2005-06-02 2005-07-13 Creative Peptides Sweden Ab Sustained release preparation of pro-insulin C-peptide
US20110034385A1 (en) * 2008-04-07 2011-02-10 National Institute Of Immunology Compositions Useful for the Treatment of Diabetes and Other Chronic Disorder

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
MY102411A (en) * 1986-12-23 1992-06-17 Ciba Geigy Ag Nasal solutions

Also Published As

Publication number Publication date
DE69231263D1 (de) 2000-08-24
CA2066532C (en) 2003-08-19
CY2246B1 (en) 2003-07-04
GB9108634D0 (en) 1991-06-12
DK0510913T3 (da) 2000-10-16
AU1506692A (en) 1992-10-29
GR3034414T3 (en) 2000-12-29
DE69231263T2 (de) 2000-12-21
JPH05139993A (ja) 1993-06-08
KR100245534B1 (ko) 2000-03-02
JP3532580B2 (ja) 2004-05-31
CA2066532A1 (en) 1992-10-24
IL101622A (en) 1996-06-18
EP0510913B1 (en) 2000-07-19
MX9201825A (es) 1992-10-01
NZ242440A (en) 1993-10-26
EP0510913A2 (en) 1992-10-28
ES2150418T3 (es) 2000-12-01
EP0510913A3 (en) 1993-12-15
US5593962A (en) 1997-01-14
AU653395B2 (en) 1994-09-29
IE921278A1 (en) 1992-11-04
ATE194775T1 (de) 2000-08-15
PT510913E (pt) 2000-12-29
IL101622A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
MX9204229A (es) Trifluorometilbencilfosfonatos utiles en el tratamiento de osteoporosis.
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
CY2424B1 (en) Pharmaceutical composition for use in treatment ofdiabetes.
EP1049664A4 (en) INHIBITION OF RAF KINASE USING SYMMETRIC AND ASYMMETRIC SUBSTITUTED DIPHENYLUREES
GR3035682T3 (en) Non-glycosylated fgf-4 and compositions containing the same.
IL87421A0 (en) Pharmaceutical compositions containing 5-amino(or substituted amino)-1,2,3-triazoles
SE9802937D0 (sv) Novel compounds
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
GB9108634D0 (en) Pharmaceutical compositions
ZA966578B (en) Pharmaceutical composition.
AP9200355A0 (en) "Therapeutic agent"
IL108197A0 (en) Pharmaceutical composition for preventing or treating arterioscleriosis
IL140044A0 (en) Compounds with growth hormone releasing properties
ZA966953B (en) Pharmaceutical composition.
IL89392A (en) Compositions for the treatment of osteoporosis in humans comprising 24, 25-dihydroxy-vitamin d3
GB9217547D0 (en) Leather treatment compositions
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
EP0495226A3 (en) 3-aryl-5-alkylthio-4h-1,2,4-triazoles for treatment of hyperreflexia due to spinal trauma
GB2262886B (en) N-channel calcium antagonists useful for treating bronchial diseases
PH31066A (en) Treatment composition.
ZA96446B (en) Use of 3,4-diphenyl chromans for the manufacture of pharmaceutical composition for the treatment or prophylaxis of obesity
IT1264562B1 (it) Composizione farmaceutica per l'applicazione topica di 17,b estradiolo nel trattamento della cheratocongiuntivite sicca